Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids—and which might only suffer their side effects—with help from a dozen clinical ...
Feb 20, 2019
0
2
(HealthDay)—In a statement issued by the American Academy of Otolaryngology-Head and Neck Surgery, recommendations are presented for the treatment of Bell's palsy after COVID-19 vaccination and for unvaccinated patients.
Feb 5, 2021
0
1
The Lundquist Institute spinoff start-up company Vitalex Biosciences, founded by researcher Dr. Ashraf Ibrahim, is producing an antibody that stems the spread of mucormycosis, a deadly fungal infection with an overall mortality ...
May 17, 2021
0
3
A new study led by the University of Leicester to understand how to improve the health of severe asthma patients has made a breakthrough finding.
Oct 27, 2016
0
2
Researchers comparing leading treatment approaches for patients with severe uveitis have discovered that systemic therapy with oral corticosteroids and immunosuppression can preserve or improve vision in the long term better ...
May 6, 2017
0
32
A Henry Ford Hospital study has found that using two types of common asthma medications in combination reduces severe asthma attacks.
Feb 6, 2012
0
0
McMaster University research, published online today by the Annals of Internal Medicine, has demonstrated the benefits of corticosteroid therapy for one of the most common serious medical conditions.
Aug 10, 2015
0
53
Compared with biologic therapy, corticosteroid (steroid) use is associated with a nearly five-fold increase of venous thromboembolism in inflammatory bowel disease (IBD) patients, according to a new study in Clinical Gastroenterology ...
Jan 29, 2015
0
18
Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults with moderate-to-severe ...
May 19, 2021
0
15
(HealthDay)—Patients with localized scleroderma (morphea) often experience delay in diagnosis and variability in treatment that is based more on the specialty of the provider than disease characteristics, according to a ...
Oct 17, 2012
0
0
